If docetaxel treatment was not an option for the patients or if the primary treatment goal was the relief of symptoms, the so - called «symptom control,» and the prevention of complications, the G - BA specified BSC as appropriate comparator therapy (BSC population).
Not exact matches
If prolongation of life was the primary therapeutic objective and the patients were eligible for
docetaxel treatment, the G - BA specified
docetaxel in combination with prednisone or prednisolone as appropriate comparator therapy (
docetaxel population).
The main purpose of this study is to find out more about the side effects of the study drug, MM - 121, when combined with the study drugs,
docetaxel or pemetrexed, and to learn
if cancer cell growth (disease progression) is delayed in people taking MM - 121 with
docetaxel or pemetrexed.